{"id":"hrs-1893-tablets","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL601986","moleculeType":"Small molecule","molecularWeight":"485.10"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Limited public information is available regarding the specific molecular mechanism of HRS-1893. As a Phase 3 candidate from Shandong Suncadia Medicine Co., Ltd., the drug is in late-stage clinical development, but detailed mechanistic data has not been widely disclosed in accessible pharmaceutical databases or literature.","oneSentence":"HRS-1893 is an investigational small molecule with unknown mechanism of action in Phase 3 development.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:45:39.230Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07479641","phase":"PHASE1","title":"A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants","status":"NOT_YET_RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2026-03","conditions":"Cardiomyopathy","enrollment":36},{"nctId":"NCT07272330","phase":"PHASE1","title":"A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects","status":"RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2025-12-11","conditions":"Cardiomyopathy","enrollment":38},{"nctId":"NCT07269717","phase":"PHASE2","title":"A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction","status":"NOT_YET_RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2025-12","conditions":"Heart Failure With Preserved Ejection Fraction","enrollment":48},{"nctId":"NCT06775834","phase":"PHASE1","title":"Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function","status":"COMPLETED","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2025-02-11","conditions":"Hypertrophic Cardiomyopathy","enrollment":24},{"nctId":"NCT07021963","phase":"PHASE2","title":"A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy","status":"RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2025-07-04","conditions":"Hypertrophic Cardiomyopathy","enrollment":300},{"nctId":"NCT07021976","phase":"PHASE3","title":"A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy","status":"RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2025-08-11","conditions":"Obstructive Hypertrophic Cardiomyopathy","enrollment":216},{"nctId":"NCT06816251","phase":"PHASE2","title":"A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy","status":"RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2025-02-25","conditions":"Non-obstructive Hypertrophic Cardiomyopathy","enrollment":84},{"nctId":"NCT05879523","phase":"PHASE1","title":"A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy","status":"COMPLETED","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2023-06-05","conditions":"Obstructive Hypertrophic Cardiomyopathy","enrollment":76},{"nctId":"NCT06354556","phase":"PHASE1","title":"Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects","status":"COMPLETED","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2024-04-26","conditions":"Obstructive Hypertrophic Cardiomyopathy","enrollment":14}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":46976,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"HRS-1893 Tablets","genericName":"HRS-1893 Tablets","companyName":"Shandong Suncadia Medicine Co., Ltd.","companyId":"shandong-suncadia-medicine-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}